<DOC>
	<DOCNO>NCT02672137</DOCNO>
	<brief_summary>Cluster randomize open-label experimental study multi-center 24 hospital either knowledge translation v usual care improve care patent hospitalize acute coronary syndrome .</brief_summary>
	<brief_title>Knowledge Translation Patients With Acute Coronary Syndromes</brief_title>
	<detailed_description>The AMI-OPTIMA study cluster randomize control trial 24 hospital one-year knowledge translation ( KT ) vs usual care . Prior randomization , review chart 100 consecutive acute coronary syndrome ( ACS ) patient participate hospital 2009 . During one year , hospital randomize KT complete : 1 ) revision recent American Heart Association Guidelines ACS management , 2 ) focus group identify solve local care gap , 3 ) local champion team promote evidence-based medical therapy ( EBMT ) . At end 12-month KT/usual care , review discharge prescription 100 consecutive ACS patient participate hospital ( year 2012 ) . EBMT pre-defined in-hospital anticoagulation discharge prescription dual anti-platelets , beta-blockers , statin , angiotensin pathway modulate agent ( patient impair leave ventricular systolic function ) . Refusal , impair cognitive function , allergy intolerance patient EBMT consider valid reason withhold EBMT .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>Had final discharge diagnosis one follow category : 1 . Myocardial infarction STsegment elevation 2 . Myocardial infarction without STsegment elevation 3 . Unstable angina 4 . Acute coronary syndrome 1 . Nonatherosclerotic coronary artery disease ( confirm coronary angiogram noninvasive test stress test , coronary CTscan , nuclear scan ) 2 . Hospital stay less 48 hour</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>knowledge transfer</keyword>
	<keyword>acute coronary syndrome</keyword>
</DOC>